FDA Accepts Bristol Myers Squibb (BMY) NDA for Iberdomide With Priority Review

3 weeks ago 13

Maham Fatima

Tue, February 24, 2026 astatine 1:11 AM CST 2 min read

Bristol-Myers Squibb Company (NYSE:BMY) is 1 of the best worth stocks to bargain now. On February 17, Bristol Myers Squibb announced that the FDA accepted its NDA for iberdomide, which is an investigational attraction for patients with relapsed oregon refractory aggregate myeloma/RRMM. If approved, iberdomide would go the archetypal successful a caller people of oral medicines known arsenic cereblon E3 ligase modulator agents. The FDA granted the exertion Priority Review and Breakthrough Therapy Designation, mounting a people enactment day of August 17 this year.

The exertion is supported by information from the Phase 3 EXCALIBER-RRMM trial, which compared iberdomide successful operation with daratumumab and dexamethasone against a modular three-drug regimen. A cardinal item of this filing is the usage of Minimal Residual Disease/MRD negativity arsenic a superior endpoint. MRD measures the tiny fig of crab cells remaining successful the assemblage that accepted tests cannot find; achieving MRD negativity is simply a highly delicate indicator that a attraction is efficaciously clearing the illness and whitethorn foretell longer periods of remission.

FDA Accepts Bristol Myers Squibb (BMY) NDA for Iberdomide With Priority Review

Pixabay/Public domain

Iberdomide works done targeted macromolecule degradation, a process wherever the cause tags circumstantial cancer-promoting proteins for demolition by the cell’s interior recycling system. This attack builds connected Bristol-Myers Squibb Company’s (NYSE:BMY) long-standing past with immunomodulatory drugs, aiming to supply a much potent oral enactment with a manageable information profile.

Bristol-Myers Squibb Company (NYSE:BMY) discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

While we admit the imaginable of BMY arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Most Profitable Undervalued Stocks to Buy and 11 Best Mining Stocks to Buy According to Wall Street.

Disclosure: None.

Read Entire Article